ArticleMicroorganisms2025
Control of Airborne and Surface Microorganisms in Real Indoor Environments Using an Integrated System of Vaporized Free Chlorine Components and Filtration.
Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Airborne and surface-residing microorganisms in indoor environments pose potential risks for infectious disease transmission. To address this issue, we developed a composite device combining a generator of vaporized free chlorine components with a fine particle removal filter. Field tests were conducted in occupied university classrooms to evaluate the device's efficacy in reducing airborne bacterial loads. Airborne bacteria were sampled under three operational conditions [Electrolyzed (+)/Filter (+), Electrolyzed (-)/Filter (+), and Electrolyzed (-)/Filter (-)]. Significant reductions in bacterial counts were observed in the Electrolyzed (+)/Filter (+) condition, with a residual rate of 14.5% after 2.25 h (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.